4//SEC Filing
RIEFLIN WILLIAM JL 4
Accession 0001209191-23-029189
CIK 0001426332other
Filed
May 11, 8:00 PM ET
Accepted
May 12, 5:52 PM ET
Size
5.7 KB
Accession
0001209191-23-029189
Insider Transaction Report
Form 4
RIEFLIN WILLIAM JL
DirectorExecutive Chairman
Transactions
- Award
Stock Option (Right to Buy)
2023-05-10+78,407→ 78,407 totalExercise: $3.69Exp: 2033-05-09→ Common Stock (78,407 underlying)
Footnotes (1)
- [F1]The stock option shall vest in four (4) approximately equal quarterly installments, such that the option shall be fully vested on the earlier of (i) the one-year anniversary of the date of grant and (ii) the day prior to the Issuer's next annual stockholder meeting, subject to the Reporting Person's Continuous Service (as defined in the Amended and Restated 2018 Equity Incentive Plan) on each applicable vesting date.
Documents
Issuer
NGM BIOPHARMACEUTICALS INC
CIK 0001426332
Entity typeother
Related Parties
1- filerCIK 0001182471
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 5:52 PM ET
- Size
- 5.7 KB